Recurrent Fetal Loss and Antiphospholipid Antibodies: Clinical and Therapeutic Aspects

Recurrent fetal losses indicate screening for antiphospholipid antibodies, especially after the third consecutive fetal loss, or when they occur after 12 weeks gestation or when the mother presents with thrombosis or other ailments of antiphospholipid syndrome. Fetal loss may be caused by thromboses...

Descripción completa

Detalles Bibliográficos
Autores principales: Blétry, O., Piette, A.-M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364563/
https://www.ncbi.nlm.nih.gov/pubmed/18476173
http://dx.doi.org/10.1155/S1064744997000288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364563/
https://www.ncbi.nlm.nih.gov/pubmed/18476173
http://dx.doi.org/10.1155/S1064744997000288

Ejemplares similares